Skip to content

Clinical trials

Phase 3 Myocardial Ischemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Ischemia Phase: Phase 3 Clear all

118 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20023
20033
20046
20058
20068
20073
20084
20094
20101
20112
20121
20134
20151
20163
20171
20191
20215
20222
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed94
Unknown status9
Terminated8
Withdrawn4
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)33
Abbott Medical Devices5
University of Washington5
Sanofi3
Brigham and Women's Hospital2
Carelon Research2
Mayo Clinic2
Meshalkin Research Institute of Pathology of Circulation2
Ministry of Health, Brazil2
Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Ischemia118
Cardiovascular Diseases58
Heart Diseases58
Coronary Disease56
Myocardial Infarction35
Coronary Artery Disease32
Angina Pectoris15
Ischemia10
Vascular Diseases9
Acute Coronary Syndrome8

Trials

Showing 51 to 75 of 118. Each trial links to its page on Pharma Observatory.

18 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.